This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Aligos Therapeutics, Inc.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Innovations by Chia-Cheng Kao in Viral Infection Treatment
Introduction
Chia-Cheng Kao is an accomplished inventor based in Brisbane, CA (US). He has made significant contributions to the field of virology through his innovative approaches to treating viral infections. His work focuses on methods that target the underlying mechanisms of viral replication, providing new avenues for therapeutic intervention.
Latest Patents
Chia-Cheng Kao holds 1 patent for his invention titled "Methods of reducing virus molecule levels." This patent describes techniques for reducing levels of virus molecules and treating viral infections. The methods involve contacting cells with an oligonucleotide inhibitor that targets a cellular host factor, which can be a target RNA or target protein involved in viral replication. The pharmaceutical composition can include such an oligonucleotide inhibitor in an effective amount for treating infections, including hepatitis B and respiratory viruses like coronaviruses.
Career Highlights
Kao is currently associated with Aligos Therapeutics, Inc., where he continues to advance his research in viral therapies. His work is pivotal in developing innovative solutions to combat viral infections, which remain a significant public health challenge.
Collaborations
Chia-Cheng Kao collaborates with notable colleagues, including Lawrence M Blatt and Leonid Beigelman. These partnerships enhance the research efforts at Aligos Therapeutics, Inc., fostering a collaborative environment that drives innovation.
Conclusion
Chia-Cheng Kao's contributions to the field of virology through his patent on reducing virus molecule levels exemplify the importance of innovation in addressing viral infections. His work at Aligos Therapeutics, Inc. continues to pave the way for new therapeutic strategies.